111 related articles for article (PubMed ID: 6665348)
1. [Parameters of hemostasis in Behçet's disease].
Dupuy E; Tobelem G; Bourgeois P; Soria C; Pellerin A; Bellucci S; Caen JP
Rev Med Interne; 1983 Dec; 4(4):317-21. PubMed ID: 6665348
[TBL] [Abstract][Full Text] [Related]
2. [Is Behçet's disease associated with characteristic abnormalities of coagulation and fibrinolysis? Apropos of 70 case reports].
Conard J; Horellou MH; Wechsler B; Fassin D; Bletry O; Godeau P; Samama M
J Mal Vasc; 1988; 13(3):257-61. PubMed ID: 3171405
[TBL] [Abstract][Full Text] [Related]
3. Coagulation and fibrinolytic activity in Behçet's disease.
Hampton KK; Chamberlain MA; Menon DK; Davies JA
Thromb Haemost; 1991 Sep; 66(3):292-4. PubMed ID: 1745999
[TBL] [Abstract][Full Text] [Related]
4. Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin.
Espinosa G; Font J; Tàssies D; Vidaller A; Deulofeu R; López-Soto A; Cervera R; Ordinas A; Ingelmo M; Reverter JC
Am J Med; 2002 Jan; 112(1):37-43. PubMed ID: 11812405
[TBL] [Abstract][Full Text] [Related]
5. Platelet function, blood coagulation and fibrinolysis in Behcet's syndrome.
Stathakis NE; Economopoulos TC; Papayannis AG; Thomopoulos D
Blut; 1977 Mar; 34(3):215-22. PubMed ID: 843627
[TBL] [Abstract][Full Text] [Related]
6. Defective fibrinolysis in Behçet's syndrome: significance and possible mechanisms.
Aitchison R; Chu P; Cater DR; Harris RJ; Powell RJ
Ann Rheum Dis; 1989 Jul; 48(7):590-3. PubMed ID: 2505697
[TBL] [Abstract][Full Text] [Related]
7. Factual or artificial inhibition of fibrinolysis and the occurrence of venous thrombosis in 3 cases of Behçet's disease.
Kluft C; Michiels JJ; Wijngaards G
Scand J Haematol; 1980 Nov; 25(5):423-30. PubMed ID: 6452679
[TBL] [Abstract][Full Text] [Related]
8. [Subclinical pro-thrombotic state in a relapse of Behcet's disease--case report].
Undas A; Pinis G
Pol Arch Med Wewn; 1996 Sep; 96(3):258-62. PubMed ID: 9122017
[TBL] [Abstract][Full Text] [Related]
9. [Myocardial infarction in Behçet's disease].
Le Thi Huong Du; Wechsler B; Kahn JC; Benhamou E; Cajfinger F; Le Hoang P; Godeau P
Arch Mal Coeur Vaiss; 1987 Oct; 80(11):1663-7. PubMed ID: 3128210
[TBL] [Abstract][Full Text] [Related]
10. Decreased fibrinolysis in Behçet's disease.
Chajek T; Aronowski E; Izak G
Thromb Diath Haemorrh; 1973 Jun; 29(3):610-8. PubMed ID: 4761829
[No Abstract] [Full Text] [Related]
11. [Plasma coagulation and fibrinolysis parameters in patients with vascular Behçet's disease, and analysis of the multimeric structure of von Willebrand factor (vWF)].
Kagawa H; Okubo S
Ryumachi; 1993 Oct; 33(5):416-23. PubMed ID: 8256164
[TBL] [Abstract][Full Text] [Related]
12. Do hemorheological alterations play any role in the development of thrombotic events in Behçet's disease?
Vayá A; Ricart J; Todolí J; Micó L; Contreras T; Aznar J
Clin Hemorheol Microcirc; 2004; 30(3-4):411-4. PubMed ID: 15258375
[TBL] [Abstract][Full Text] [Related]
13. [Blood coagulation and fibrinolysis in patients with Behçet's disease].
Fusegawa H; Ichikawa Y; Tanaka Y; Miyachi Y; Kawada T; Gondo K; Ikeda M; Shimizu H; Arimori S; Ando Y
Rinsho Byori; 1991 May; 39(5):509-16. PubMed ID: 2072574
[TBL] [Abstract][Full Text] [Related]
14. Endothelial cell activation and hypercoagulability in ocular Behçet's disease.
Probst K; Fijnheer R; Rothova A
Am J Ophthalmol; 2004 May; 137(5):850-7. PubMed ID: 15126149
[TBL] [Abstract][Full Text] [Related]
15. [Deep venous thrombosis in Behçet's disease. 106 localizations in a series of 177 patients].
Wechsler B; Piette JC; Conard J; Huong Du LT; Blétry O; Godeau P
Presse Med; 1987 Apr; 16(14):661-4. PubMed ID: 2952991
[TBL] [Abstract][Full Text] [Related]
16. Haemostasis, thrombosis, and endothelium in Behçet's disease.
Haznedaroğlu IC; Celik I; Büyükaşik Y; Koşar A; Kirazli S; Dündar SV
Acta Haematol; 1998; 99(4):236-7. PubMed ID: 9644305
[No Abstract] [Full Text] [Related]
17. Lp(a) lipoprotein levels as a predictor of risk for thrombogenic events in patients with Behçet's disease.
Orem A; Değer O; Memiş O; Bahadir S; Ovali E; Cimşit G
Ann Rheum Dis; 1995 Sep; 54(9):726-9. PubMed ID: 7495343
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the fibrinolytic system in Behçet's disease?
Asbeck F; Meyer-Boernecke D; van de Loo J
Haemostasis; 1977; 6(5):303-9. PubMed ID: 598751
[TBL] [Abstract][Full Text] [Related]
19. Thrombin activatable fibrinolysis inhibitor in Behçet's disease.
Donmez A; Aksu K; Celik HA; Keser G; Cagirgan S; Omay SB; Inal V; Aydin HH; Tombuloglu M; Doganavsargil E
Thromb Res; 2005; 115(4):287-92. PubMed ID: 15668188
[TBL] [Abstract][Full Text] [Related]
20. Impaired haemostatic kinetics and endothelial function in Behçet's disease.
Haznedaroglu IC; Ozcebe OI; Ozdemir O; Celik I; Dündar SV; Kirazli S
J Intern Med; 1996 Oct; 240(4):181-7. PubMed ID: 8918508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
